Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study C Onal, YX Li, RC Miller, P Poortmans, N Constantinou, DC Weber, ... Annals of Oncology 22 (1), 156-164, 2011 | 116 | 2011 |
Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer Ş İğdem, G Alço, T Ercan, M Barlan, K Ganiyusufoğlu, B Ünalan, S Turkan, ... International Journal of Radiation Oncology* Biology* Physics 77 (3), 818-823, 2010 | 95 | 2010 |
Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study K Khanfir, A Kallel, S Villette, Y Belkacémi, C Vautravers, TD Nguyen, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 2118-2124, 2012 | 79 | 2012 |
Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network DC Weber, RC Miller, S Villà, P Hanssens, BG Baumert, P Castadot, ... International Journal of Radiation Oncology* Biology* Physics 66 (1), 179-186, 2006 | 68 | 2006 |
Dosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer T Ercan, Ş İğdem, G Alço, F Zengin, S Atilla, M Dinçer, S Okkan Japanese journal of radiology 28, 283-289, 2010 | 62 | 2010 |
Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity S Igdem, H Akpinar, G Alço, F Agacayak, S Turkan, S Okkan The British Journal of Radiology 82 (983), 941-945, 2009 | 60 | 2009 |
Information needs of early-stage prostate cancer patients: a comparison of nine countries D Feldman-Stewart, C Capirci, S Brennenstuhl, C Tong, U Abacioglu, ... Radiotherapy and Oncology 94 (3), 328-333, 2010 | 50 | 2010 |
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients GUL Alco, A Bozdogan, D Selamoglu, KN Pilancı, S Tuzlalı, C Ordu, ... Oncology letters 9 (3), 1046-1054, 2015 | 48 | 2015 |
Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study. OP Erpolat, G Alco, HB Caglar, S Igdem, A Saran, N Dagoglu, I Aslay, ... European journal of gynaecological oncology 35 (1), 62-66, 2014 | 48 | 2014 |
Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study U Schick, Y Bolukbasi, J Thariat, R Abdah-Bortnyak, A Kuten, S Igdem, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), e757-e763, 2012 | 39 | 2012 |
Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation … P Hurmuz, C Onal, G Ozyigit, S Igdem, B Atalar, H Sayan, Z Akgun, M Kurt, ... Strahlentherapie und Onkologie 196, 1034-1043, 2020 | 36 | 2020 |
Vitamin D levels in patients with breast cancer: importance of dressing style G Alco, S Igdem, M Dincer, V Ozmen, S Saglam, D Selamoglu, Z Erdogan, ... Asian Pacific Journal of Cancer Prevention 15 (3), 1357-1362, 2014 | 35 | 2014 |
Primary pineal tumors: outcome and prognostic factors—a study from the Rare Cancer Network (RCN) S Villà, RC Miller, M Krengli, H Abusaris, BG Baumert, S Servagi-Vernat, ... Clinical and Translational Oncology 14, 827-834, 2012 | 30 | 2012 |
Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies G Geceer, S Okkan, A Öber, S Turkan Eur. J. Gynaec. Oncol.-ISSN 30 (5), 2009, 2009 | 29 | 2009 |
Replacement of the tumor bed following oncoplastic breast‑conserving surgery with immediate latissimus dorsi mini‑flap G Alço, S Igdem, S Okkan, M Dincer, D Sarsenov, AS Ilgun, F Agacayak, ... Molecular and clinical oncology 5 (4), 365-371, 2016 | 27 | 2016 |
Information for decision making by patients with early-stage prostate cancer: a comparison across 9 countries D Feldman-Stewart, C Capirci, S Brennenstuhl, C Tong, U Abacioglu, ... Medical Decision Making 31 (5), 754-766, 2011 | 27 | 2011 |
Impact of adjuvant chemoradiotherapy for rectal cancer on the long-term quality of life and late side effects: a multicentric clinical evaluation by the Turkish Oncology Group. D Kilic, D Yalman, M Aksu, B Atasoy, S Igdem, F Dincbas, Ş YALÇIN Asian Pacific journal of cancer prevention: APJCP 13 (11), 2012 | 26 | 2012 |
The application of positron emission tomography/computed tomography in radiation treatment planning: effect on gross target volume definition and treatment management Ş İğdem, G Alço, T Ercan, B Ünalan, B Kara, G Geceer, C Akman, ... Clinical Oncology 22 (3), 173-178, 2010 | 22 | 2010 |
Prostatic duct adenocarcinoma: clinical characteristics, treatment options, and outcomes–a rare cancer network study Ş Iğdem, DY Spiegel, J Efstathiou, RC Miller, PMP Poortmans, S Koca, ... Oncology Research and Treatment 33 (4), 169-173, 2010 | 21 | 2010 |
Oligometastatic bone disease in castration-sensitive prostate cancer patients treated with stereotactic body radiotherapy using 68Ga-PSMA PET/CT: TROD 09-004 study C Onal, G Ozyigit, Z Akgun, B Atalar, S Igdem, E Oymak, F Agaoglu, ... Clinical nuclear medicine 46 (6), 465-470, 2021 | 20 | 2021 |